OHSU is one of four U.S. civilian hospitals helping train Army medics, licensed practical nurses and other health professionals through the Strategic Medical Asset Readiness Training program. Martin Schreiber, M.D., says the program helps soldiers maintain their health care skills during times of peace.

In a feature about OHSU’s efforts to train medical residents who are unable to practice abortion care in their home state, Alyssa Colwill, M.D., says: “There are large ripple effects of these harmful policies that aren’t just limited to somebody trying to get an abortion. It is interrupting the obstetrics and gynecology field.”

OHSU and other hospitals collaborated with the Oregon Nurses Association, Service Employees International Union and others on Oregon House Bill 2697, which, if it passes in the Senate, would create nurse-to-patient ratios in certain hospital unit types.

Continued coverage of the collaboration between the Portland Police Bureau and OHSU Knight Cancer Institute researchers, led by Jeff Tyner, Ph.D., to help police take a data-driven approach to stolen vehicle operations. During their first five operations without this approach, for every 31 stops, they only came across one stolen car; now it’s one in six.

Archie Bleyer, M.D., discusses the increase in cancer rates in young people, noting the surge in thyroid and kidney cancer is at least partly a result of “overdiagnosis,” due to increased screenings for cancer and other health concerns.

In a story explaining how Oregon law doesn’t legalize psychedelics as a medical therapy and instead legalizes their “supported adult use,” Aryan Sarparast, M.D., notes promising results from a clinical trial investigating psychedelics as medical therapy

Ajit Jetmalani, M.D., highlights Oregon’s efforts to address the rising rates of suicide among young people in the U.S., citing Oregon’s youth suicide prevention strategy, which involves a suicide and depression screening at every medical appointment and having all school-run programs identify high-risk youth.

-- In an article on new treatment options for patients with gastrointestinal stromal tumors, or GIST, Michael Heinrich, M.D., says: “The key to managing these neuro-cognitive side effects is early recognition of them, modifying the dose, and doing dose interruptions.”

Continued coverage of the newly formed Knight Cancer Precision Biofabrication Hub led by Luiz Bertassoni, D.D.S., Ph.D., to develop organs, bone for pioneering research into cancer, and more.

In updated coverage about the FDA approving the nation’s first over-the-counter birth control pill, Alison Edelman, M.D., says the pill, which only has progestin and not a combination of progestin and estrogen, “is way safer than many of the medications we have over the counter currently.”